Sign in

CIK 0001501989 · Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273521219
Phone
650.515.3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
  1. SCHEDULE 13G Stake Statement of Beneficial Ownership
  2. 8-K Event Results of operations
  3. 10-Q Report Quarterly Report
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. 4/A Planned sale CEO sold 101,793 shares at $4.54 ($461,906)
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. SCHEDULE 13G Stake Statement of Beneficial Ownership
  9. S-8 Other Securities Offered to Employees in Benefit Plans
  10. 8-K Event Results of operations
  11. 10-Q Report Quarterly Report
  12. 4 Grant or award Chief Legal Officer acquired 100,000 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. SCHEDULE 13G Stake Statement of Beneficial Ownership
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. SCHEDULE 13G Stake Statement of Beneficial Ownership
  18. 8-K Event Executive or director change
  19. 4 Derivatives Options or other derivatives
  20. 8-K Event Executive or director change · Bylaws or fiscal year change · Shareholder vote results

Page 1 of 41 · 801 filings